Day One Biopharmaceuticals Soars 4.53% on New Certificate!

viernes, 6 de junio de 2025, 2:24 pm ET1 min de lectura
DAWN--
Day One Biopharmaceuticals, Inc. rose 4.53% intraday, with the company receiving a registration certificate for a new product. Additionally, UBSUBS-- maintained a Neutral rating on the stock, although it decreased the target price from EUR 302 to EUR 230.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios